Description Update of the 2009 started Continuous Assessment of molecular diagnostics from the end user perspective. Hospital and private laboratories have systematically been surveyed to collect information on number of labs testing, NA tests, test volumes, used platforms (separated for amplification, hybridization, detection) and reagents.
For data reliability and accurate projections at segment level a 3 step methodology has been applied: Step 1: Identification of the total number of labs Step 2: Identification of the total number of laboratories using NA technologies (in several lab units per hospital) Step 3: Interviews with NA laboratories on NA test volume, kits, platforms and trends. A list of 39 NA tests has been provided to the labs for structured data entry.
The report covers key platforms of molecular diagnostics, including Polymerase Chain Reaction (PCR), Real Time PCR (RT-PCR), Traditional and Next Generation Sequencing, TMA, LCR, NASBA, SDA, HCA, bDNA.
Executive Summary dii is an international market research company entirely specialised in healthcare markets providing market information and support to strategic business decisions. In cooperation with key industry we have desigend the Continuous Molecular Market Assessment which has been realized in 2009, 2012, 2014 and 2016 with the 2 main objectives: 1) Assess market size and shares for molecular diagnostics (# of labs using which technology, test volumes, platforms and reagents) 2) Understand long term trends and needs
Format of deliverables Excel - detailed data reports with extrapolation of # of labs, test volumes, market shares for platforms and reagents per country & test
Our reports have been used by over 10K customers, including:
2018 Emerging Molecular Diagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers This 185-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies,...
Global Molecular Diagnostics Market to Reach $29.68 Billion by 2028 Since the dawn of the precision medicine era, the entire gamut of the healthcare industry has witnessed a paradigm change toward more precise diagnostics.The increasing prevalence of chronic disorders and an overall increased demand for preventive medication...
2019 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Emerging Technologies and Strategic Profiles of Leading Suppliers This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA...
2019-2023 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Sales Forecasts and Strategic Profiles of Leading Suppliers This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as...
2019 Global Nucleic Acid Testing/NAT Market: Supplier Shares by Country, Facilities, Test Volumes, and Sales Forecasts by Country This report provides: - Worldwide overview of the molecular diagnostics market, including France, Germany, Italy, Japan, Spain, UK and USA. - Estimates of facilities performing...
2019-2023 Molecular Diagnostics Market: Supplier Shares and Sales Forecasts by Country, Strategic Profiles of Leading Suppliers This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test...
Report Synopsis Emergence of novel next generation sequencing technologies, extensive use of next generation sequencing technologies in clinical diagnostics, application of sequencing technologies in cancer to detect mutations are some of the factors fueling the growth of sequencing technologies usage in the molecular diagnostics...
The increasing adoption of targeted therapy over traditional therapy is expected to drive the overall growth of the immuno-oncology assays market. The immuno-oncology assays market is expected to grow from USD 2.9 billion in 2018 to USD 5.9 billion by 2024, at a CAGR of 12.7% during the forecast period. The immuno-oncology...
2018 Emerging Virology and Bacteriology Diagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers This 155-page report provides detailed analyses of current and emerging technologies, and their potential applications for the infectious disease testing market, including molecular diagnostics,...
2018 Emerging Immunodiagnostic Technologies, Country Market Shares, Strategic Profiles of Leading Suppliers This 145-page report reviews potential market applications of current and emerging clinical chemistry and immunodiagnostic technologies, including monoclonal and polyclonal antibodies, immunoassays, IT, dry...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.